TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IFRX

InflaRx N.V.

Healthcare · Biotechnology

1.80$ -3.7% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

InflaRx N.V. (IFRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 167 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IFRX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
129 120 107 93 80 76 87 73 65 55 49 167
128 109 103 91 74 72 86 66 63 54 47 165
22 13 25 19 26 18 47 13 6.4 16 15 147
23 13 25 19 26 18 66 48 45 46 40 158
3.4 3.8 0.0 0.0 0.1 1.7 1.7 1.8 – 1.4 1.7 1.6
1.6 11 11 9.6 9.7 6.9 6.9 5.0 5.1 0.0 – –
1.4 – – – – – – – – – – –
0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1
11 18 12 11 14 15 17 16 20 14 12 21
11 17 12 10 14 14 16 16 19 13 11 20
0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.3
6.0 5.1 7.6 8.5 12 3.4 8.4 9.7 9.2 5.4 0.4 5.3
118 103 95 82 65 61 70 57 45 42 37 146
-270 -286 -296 -310 -327 -332 -341 -355 -367 -378 -384 -394
59 59 59 59 59 59 63 68 68 67 72 118

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?